Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
January 17, 2019
Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment
Yandong Shen, Kyle Crassini, Suneet Sandhu, et al.
Haematologica
|
June 1, 2010
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
David Oscier, Rachel Wade, Zadie Davis, et al.
Journal of Ophthalmic Inflammation and Infection
|
April 25, 2023
Human retinal endothelial cells express functional interleukin-6 receptor
Lisia Barros Ferreira, Liam M Ashander, Binoy Appukuttan, et al.
Cytokine
|
November 4, 2023
Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells
Lisia Barros Ferreira, Liam M Ashander, Yuefang Ma, et al.
Leukemia & Lymphoma
|
June 19, 2018
Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells
Kyle Crassini, Tahni Pyke, Yandong Shen, et al.
British Journal of Haematology
|
September 27, 2014
Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management
Nada Hamad, David Kliman, O Giles Best, et al.
British Journal of Haematology
|
April 14, 2021
Insight into del17p low-frequency subclones in chronic lymphocytic leukaemia (CLL): data from the Australasian Leukaemia and Lymphoma Group (ALLG)/CLL Australian Research Consortium (CLLARC) CLL5 trial
Cuc Do, O Giles Best, Lauren Thurgood, et al.
Blood Advances
|
October 21, 2020
IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment
Yandong Shen, Kyle Crassini, Narjis Fatima, et al.
Frontiers in Cellular and Infection Microbiology
|
June 23, 2023
Stagnation arising through intermittent usage is associated with increased viable but non culturable <i>Legionella</i> and amoeba hosts in a hospital water system
Muhammad Atif Nisar, Kirstin E Ros, Melissa H Brown, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Therapeutic approaches and drug-resistance in chronic lymphocytic leukaemia
Narjis Fatima, Kyle R Crassini, Lauren Thurgood, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
January 17, 2019
Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment
Yandong Shen, Kyle Crassini, Suneet Sandhu, et al.
Haematologica
|
June 1, 2010
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
David Oscier, Rachel Wade, Zadie Davis, et al.
Journal of Ophthalmic Inflammation and Infection
|
April 25, 2023
Human retinal endothelial cells express functional interleukin-6 receptor
Lisia Barros Ferreira, Liam M Ashander, Binoy Appukuttan, et al.
Cytokine
|
November 4, 2023
Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells
Lisia Barros Ferreira, Liam M Ashander, Yuefang Ma, et al.
Leukemia & Lymphoma
|
June 19, 2018
Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells
Kyle Crassini, Tahni Pyke, Yandong Shen, et al.
British Journal of Haematology
|
September 27, 2014
Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management
Nada Hamad, David Kliman, O Giles Best, et al.
British Journal of Haematology
|
April 14, 2021
Insight into del17p low-frequency subclones in chronic lymphocytic leukaemia (CLL): data from the Australasian Leukaemia and Lymphoma Group (ALLG)/CLL Australian Research Consortium (CLLARC) CLL5 trial
Cuc Do, O Giles Best, Lauren Thurgood, et al.
Blood Advances
|
October 21, 2020
IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment
Yandong Shen, Kyle Crassini, Narjis Fatima, et al.
Frontiers in Cellular and Infection Microbiology
|
June 23, 2023
Stagnation arising through intermittent usage is associated with increased viable but non culturable <i>Legionella</i> and amoeba hosts in a hospital water system
Muhammad Atif Nisar, Kirstin E Ros, Melissa H Brown, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
May 18, 2022
Therapeutic approaches and drug-resistance in chronic lymphocytic leukaemia
Narjis Fatima, Kyle R Crassini, Lauren Thurgood, et al.
Page
of 7